Literature DB >> 28710275

A pH-dependent switch promotes β-synuclein fibril formation via glutamate residues.

Gina M Moriarty1, Michael P Olson1, Tamr B Atieh1, Maria K Janowska1, Sagar D Khare2, Jean Baum3.   

Abstract

α-Synuclein (αS) is the primary protein associated with Parkinson's disease, and it undergoes aggregation from its intrinsically disordered monomeric form to a cross-β fibrillar form. The closely related homolog β-synuclein (βS) is essentially fibril-resistant under cytoplasmic physiological conditions. Toxic gain-of-function by βS has been linked to dysfunction, but the aggregation behavior of βS under altered pH is not well-understood. In this work, we compare fibril formation of αS and βS at pH 7.3 and mildly acidic pH 5.8, and we demonstrate that pH serves as an on/off switch for βS fibrillation. Using αS/βS domain-swapped chimera constructs and single residue substitutions in βS, we localized the switch to acidic residues in the N-terminal and non-amyloid component domains of βS. Computational models of βS fibril structures indicate that key glutamate residues (Glu-31 and Glu-61) in these domains may be sites of pH-sensitive interactions, and variants E31A and E61A show dramatically altered pH sensitivity for fibril formation supporting the importance of these charged side chains in fibril formation of βS. Our results demonstrate that relatively small changes in pH, which occur frequently in the cytoplasm and in secretory pathways, may induce the formation of βS fibrils and suggest a complex role for βS in synuclein cellular homeostasis and Parkinson's disease.
© 2017 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  Parkinson disease; beta-synuclein; computer modeling; fibril; neurodegeneration; nuclear magnetic resonance (NMR); protein aggregation; synuclein

Mesh:

Substances:

Year:  2017        PMID: 28710275      PMCID: PMC5625065          DOI: 10.1074/jbc.M117.780528

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  74 in total

1.  Axon pathology in Parkinson's disease and Lewy body dementia hippocampus contains alpha-, beta-, and gamma-synuclein.

Authors:  J E Galvin; K Uryu; V M Lee; J Q Trojanowski
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-09       Impact factor: 11.205

Review 2.  The Zyggregator method for predicting protein aggregation propensities.

Authors:  Gian Gaetano Tartaglia; Michele Vendruscolo
Journal:  Chem Soc Rev       Date:  2008-05-27       Impact factor: 54.564

Review 3.  Sensors and regulators of intracellular pH.

Authors:  Joseph R Casey; Sergio Grinstein; John Orlowski
Journal:  Nat Rev Mol Cell Biol       Date:  2009-12-09       Impact factor: 94.444

4.  Emerging insights into the mechanistic link between α-synuclein and glucocerebrosidase in Parkinson's disease.

Authors:  Ryan P McGlinchey; Jennifer C Lee
Journal:  Biochem Soc Trans       Date:  2013-12       Impact factor: 5.407

Review 5.  Exploring the accessible conformations of N-terminal acetylated α-synuclein.

Authors:  Gina M Moriarty; Maria K Janowska; Lijuan Kang; Jean Baum
Journal:  FEBS Lett       Date:  2013-03-13       Impact factor: 4.124

6.  Yeast reveals similar molecular mechanisms underlying alpha- and beta-synuclein toxicity.

Authors:  Sandra Tenreiro; Rita Rosado-Ramos; Ellen Gerhardt; Filippo Favretto; Filipa Magalhães; Blagovesta Popova; Stefan Becker; Markus Zweckstetter; Gerhard H Braus; Tiago Fleming Outeiro
Journal:  Hum Mol Genet       Date:  2015-11-18       Impact factor: 6.150

7.  A rationally designed six-residue swap generates comparability in the aggregation behavior of α-synuclein and β-synuclein.

Authors:  Cintia Roodveldt; August Andersson; Erwin J De Genst; Adahir Labrador-Garrido; Alexander K Buell; Christopher M Dobson; Gian Gaetano Tartaglia; Michele Vendruscolo
Journal:  Biochemistry       Date:  2012-10-22       Impact factor: 3.162

8.  Solution conditions determine the relative importance of nucleation and growth processes in α-synuclein aggregation.

Authors:  Alexander K Buell; Céline Galvagnion; Ricardo Gaspar; Emma Sparr; Michele Vendruscolo; Tuomas P J Knowles; Sara Linse; Christopher M Dobson
Journal:  Proc Natl Acad Sci U S A       Date:  2014-05-09       Impact factor: 11.205

9.  Role of oxidative stress in Parkinson's disease.

Authors:  Onyou Hwang
Journal:  Exp Neurobiol       Date:  2013-03-31       Impact factor: 3.261

10.  Structural and functional characterization of two alpha-synuclein strains.

Authors:  Luc Bousset; Laura Pieri; Gemma Ruiz-Arlandis; Julia Gath; Poul Henning Jensen; Birgit Habenstein; Karine Madiona; Vincent Olieric; Anja Böckmann; Beat H Meier; Ronald Melki
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

View more
  11 in total

1.  pH-Dependent fibril maturation of a Pmel17 repeat domain isoform revealed by tryptophan fluorescence.

Authors:  Dexter N Dean; Jennifer C Lee
Journal:  Biochim Biophys Acta Proteins Proteom       Date:  2019-02-02       Impact factor: 3.036

Review 2.  Interactions between the Intrinsically Disordered Proteins β-Synuclein and α-Synuclein.

Authors:  Jonathan K Williams; Xue Yang; Jean Baum
Journal:  Proteomics       Date:  2018-09-09       Impact factor: 3.984

3.  Getting in charge of β-synuclein fibrillation.

Authors:  Meytal Landau
Journal:  J Biol Chem       Date:  2017-09-29       Impact factor: 5.157

4.  A pH-eQTL Interaction at the RIT2-SYT4 Parkinson's Disease Risk Locus in the Substantia Nigra.

Authors:  Sejal Patel; Derek Howard; Leon French
Journal:  Front Aging Neurosci       Date:  2021-07-09       Impact factor: 5.750

5.  Amyloidogenic Propensities of Ribosomal S1 Proteins: Bioinformatics Screening and Experimental Checking.

Authors:  Sergei Y Grishin; Evgeniya I Deryusheva; Andrey V Machulin; Olga M Selivanova; Anna V Glyakina; Elena Y Gorbunova; Leila G Mustaeva; Vyacheslav N Azev; Valentina V Rekstina; Tatyana S Kalebina; Alexey K Surin; Oxana V Galzitskaya
Journal:  Int J Mol Sci       Date:  2020-07-22       Impact factor: 5.923

6.  Investigating the neuroprotective effect of AAV-mediated β-synuclein overexpression in a transgenic model of synucleinopathy.

Authors:  Dorian Sargent; Dominique Bétemps; Matthieu Drouyer; Jérémy Verchere; Damien Gaillard; Jean-Noël Arsac; Latifa Lakhdar; Anna Salvetti; Thierry Baron
Journal:  Sci Rep       Date:  2018-12-03       Impact factor: 4.379

7.  Sumoylation Protects Against β-Synuclein Toxicity in Yeast.

Authors:  Blagovesta Popova; Alexandra Kleinknecht; Patricia Arendarski; Jasmin Mischke; Dan Wang; Gerhard H Braus
Journal:  Front Mol Neurosci       Date:  2018-03-27       Impact factor: 5.639

Review 8.  Alternative Splicing of Alpha- and Beta-Synuclein Genes Plays Differential Roles in Synucleinopathies.

Authors:  Ana Gámez-Valero; Katrin Beyer
Journal:  Genes (Basel)       Date:  2018-01-25       Impact factor: 4.096

9.  Antioxidant Nanoparticles for Concerted Inhibition of α-Synuclein Fibrillization, and Attenuation of Microglial Intracellular Aggregation and Activation.

Authors:  Nanxia Zhao; Xue Yang; Hannah R Calvelli; Yue Cao; Nicola L Francis; Rebecca A Chmielowski; Laurie B Joseph; Zhiping P Pang; Kathryn E Uhrich; Jean Baum; Prabhas V Moghe
Journal:  Front Bioeng Biotechnol       Date:  2020-02-21

10.  Metal ions shape α-synuclein.

Authors:  Rani Moons; Albert Konijnenberg; Carl Mensch; Roos Van Elzen; Christian Johannessen; Stuart Maudsley; Anne-Marie Lambeir; Frank Sobott
Journal:  Sci Rep       Date:  2020-10-01       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.